Economic Atlas
Companies/Cronos Group Inc.
Company profile

Cronos Group Inc.

NASDAQ: CRON · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Stayner, ONCIK 0001656472Reports USD
#313 of 1,418 Healthcare companies by revenue69th-percentile growth
EA Score
69B
Revenue TTM
$205.7M
Rev growth YoY (TTM)
+65.1%
Net income (FY)
-$9.4M
Employees
610
as of 2026-08-10
Market cap
$1.2B
as of 2026-08-10

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$146.6M$146.6M2025
Net income-$9.4M-$9.4M2025
Operating income-$17.4M-$17.4M2025
Total assets$1.2B$1.2B2025
Liabilities$54.2M$54.2M2025
Equity$1.1B$1.1B2025

Revenue trend

FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Cannabis Flower74%
Cannabis Extracts26%
Product and Service, Other0%
By geography
CANADA62%
ISRAEL29%
Other Countries10%
The read

What is Cronos Group Inc.’s revenue?

Cronos Group Inc. booked $146.6M in FY2025 revenue, growing 25% year over year — faster than most Healthcare companies we track, at a -6.4% net margin.

Peers · Healthcare
Neuronetics, Inc.59CElite Pharmaceuticals, Inc.77B+GRAIL Inc.51DKaryopharm Therapeutics Inc.49DiAnthus Capital Holdings, Inc.46DInfuSystem Holdings, Inc.80B+
Key facts
CEOMichael Ryan Gorenstein
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersStayner, ON
ExchangeNASDAQ: CRON
Employees610
IPO date2018-02-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.